These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 19767378)

  • 1. Long-term stability of extemporaneously prepared captopril oral liquids in glass bottles.
    Brustugun J; Lao YE; Fagernaes C; Braenden J; Kristensen S
    Am J Health Syst Pharm; 2009 Oct; 66(19):1722-5. PubMed ID: 19767378
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of ingredients on stability of captopril in extemporaneously prepared oral liquids.
    Lye MY; Yow KL; Lim LY; Chan SY; Chan E; Ho PC
    Am J Health Syst Pharm; 1997 Nov; 54(21):2483-7. PubMed ID: 9359955
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Stability of baclofen, captopril, diltiazem hydrochloride, dipyridamole, and flecainide acetate in extemporaneously compounded oral liquids.
    Allen LV; Erickson MA
    Am J Health Syst Pharm; 1996 Sep; 53(18):2179-84. PubMed ID: 8879325
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Stability of an alternative extemporaneous captopril fast-dispersing tablet formulation versus an extemporaneous oral liquid formulation.
    Pabari RM; McDermott C; Barlow J; Ramtoola Z
    Clin Ther; 2012 Nov; 34(11):2221-9. PubMed ID: 23149007
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Influence of formulation properties on chemical stability of captopril in aqueous preparations.
    Kristensen S; Lao YE; Brustugun J; Braenden JU
    Pharmazie; 2008 Dec; 63(12):872-7. PubMed ID: 19177902
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Stability of captopril in SyrSpend SF.
    Geiger CM; Sorenson B; Whaley PA
    Int J Pharm Compd; 2013; 17(4):336-8. PubMed ID: 24261148
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Stability of flucytosine in an extemporaneously compounded oral liquid.
    Wintermeyer SM; Nahata MC
    Am J Health Syst Pharm; 1996 Feb; 53(4):407-9. PubMed ID: 8673661
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of sucrose, citric buffer and glucose oxidase on the stability of captopril in liquid formulations.
    Liu J; Chan SY; Ho PC
    J Clin Pharm Ther; 1999 Apr; 24(2):145-50. PubMed ID: 10380067
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Stability study of an aqueous formulation of captopril at 1 mg/ml].
    Escribano García MJ; Torrado Durán S; Torrado Durán JJ
    Farm Hosp; 2005; 29(1):30-6. PubMed ID: 15773800
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Stability of extemporaneously prepared glycopyrrolate oral suspensions.
    Cober MP; Johnson CE; Sudekum D; Penprase K
    Am J Health Syst Pharm; 2011 May; 68(9):843-5. PubMed ID: 21515869
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Stability of extemporaneously prepared rifaximin oral suspensions.
    Cober MP; Johnson CE; Lee J; Currie K
    Am J Health Syst Pharm; 2010 Feb; 67(4):287-9. PubMed ID: 20133533
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Stability of norfloxacin in an extemporaneously prepared oral liquid.
    Johnson CE; Price J; Hession JM
    Am J Health Syst Pharm; 2001 Apr; 58(7):577-9. PubMed ID: 11296605
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Stability of extemporaneously prepared moxifloxacin oral suspensions.
    Hutchinson DJ; Johnson CE; Klein KC
    Am J Health Syst Pharm; 2009 Apr; 66(7):665-7. PubMed ID: 19299374
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Stability of spironolactone in an extemporaneously prepared suspension at two temperatures.
    Nahata MC; Morosco RS; Hipple TF
    Ann Pharmacother; 1993 Oct; 27(10):1198-9. PubMed ID: 8251687
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparative Stability of Vitamin K1 Oral Liquids Prepared in Sterile Water for Injection and Stored in Amber Glass Bottles and Amber Plastic Syringes.
    Huffman J; Brown S; Lewis P; Lawson S; Ogle A; Peacock G
    Int J Pharm Compd; 2018; 22(4):340-344. PubMed ID: 30021190
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Stability of famotidine in an extemporaneously prepared oral liquid.
    Quercia RA; Jay GT; Fan C; Chow MS
    Am J Hosp Pharm; 1993 Apr; 50(4):691-3. PubMed ID: 8470686
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Stability of valacyclovir hydrochloride in extemporaneously prepared oral liquids.
    Fish DN; Vidaurri VA; Deeter RG
    Am J Health Syst Pharm; 1999 Oct; 56(19):1957-60. PubMed ID: 10554914
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Stability of extemporaneously prepared oxandrolone oral suspensions.
    Johnson CE; Cober MP; Hawkins KA; Julian JD
    Am J Health Syst Pharm; 2011 Mar; 68(6):519-21. PubMed ID: 21378300
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Stability of extemporaneously prepared sodium phenylbutyrate oral suspensions.
    Caruthers RL; Johnson CE
    Am J Health Syst Pharm; 2007 Jul; 64(14):1513-5. PubMed ID: 17617502
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Stability of tacrolimus in an extemporaneously compounded oral liquid.
    Jacobson PA; Johnson CE; West NJ; Foster JA
    Am J Health Syst Pharm; 1997 Jan; 54(2):178-80. PubMed ID: 9117806
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.